I-Dexcom ingaba ngumdlali omkhulu emakethe yezobuchwepheshe obunjalo sibonga ngokutholwa kwakamuva kweTypeZero Technologies, inkampani eyakhe uhlelo lokuphatha nokulawula ukulethwa kwe-insulin kumaphampu we-insulin. Umbukiso wamaphenti wokufakelwa uhlelwe ukuthi akhishwe ngo-2019.
Izindaba ezinhle kubantu abanesifo sikashukela sohlobo 1 ukuthi ukuthuthuka kwamanyikwe okudala ukuthi kugxile kakhulu kwezinye izinkampani ezinkulu zikashukela.
I-TypeZero Technologies isungule uhlelo lweselula kanye nohlelo lokulawula i-insulin olubizwa nge-inControl. Isistimu ingamisa ukulethwa kwe-insulin lapho kubikezelwa amazinga kashukela omncane, futhi ilethe imithamo ye-bolus uma amazinga kashukela wegazi ephakeme kakhulu.
I-TypeZero isivele isebenza nezinkampani eziningi ze-insulin pump, kubandakanya iTandem Diabetes Care neCellnovo. Uhlelo oluzenzakalelayo lokulethwa kwe-insulin luzobandakanya ukusebenza kwe-Dexcom ngokuqhubekayo kokuhlola ushukela, i-Tandem t: i-slim X2 insulin pump kanye ne-TypeZero inControl management system sikashukela. Kuhlelwa ukuthi uhlelo lwe-InControl TypeZero luhambisane ngamaphampu amaningi e-insulin nabaqaphi be-glucose abaqhubekayo. Lokhu kusho ukuthi uhlelo luzotholakala kubantu abahlukahlukene, hhayi nje labo abanenhlanganisela ethile yamaphampu kanye nezinhlelo zokuhlola ushukela eziqhubekayo.
Sekuvele kunenqwaba yezinkampani ezinesifo sikashukela ezisebenza kwezobuchwepheshe bokufakelwa. Ukuba khona kwenkampani enkulu ethembisayo, efana neDexcom, kule makethe kuzokwandisa amathuba abantu abanesifo sikashukela futhi kuzovuselela ukuthuthukiswa kobuchwepheshe, njengoba amafemu ezoncintisana.
